Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
A comparison of 2 different combinations of high blood pressure medications to treat...
Brief Summary
Official Title: “A Study on the Efficacy and Safety of Olmesartan Medoxomil and Its Combination With Hydrochlorothiazide Compared With an ACE Inhibitor and Its Combination With a Calcium Channel Blocker in Patients With Stage 2 Hypertension”
A comparison of 2 different combinations of high blood pressure medications to treat hypertension
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
- Study Primary Completion Date: September 2006
Intervention(s) in this Clinical Trial
- Drug: Olmesartan medoxomil
- Drug: Hydroclorothiazide
- Drug: Benazepril
- Drug: Amlodipine
Outcome Measures for this Clinical Trial
Primary Measures
- Change in systolic blood pressure from the start of the study
Secondary Measures
- Change in diastolic blood pressure from the start of the study
- Percent of patients who achieve target blood pressure goals
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Greater than 18 years of age
- Patients with high blood pressure
Exclusion Criteria:
- Hypertensive encephalopathy, stroke or transient ischemic attack within the past 6 months
- History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina pectoris within the past 6 months
- Type 1 diabetes mellitus
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Daiichi Sankyo Inc. Industry
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00185120
Study ID Number: 866-447
ClinicalTrials.gov Identifier: NCT00185120
Health Authority: United States: Food and Drug Administration
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00185120
